Publication May 14, 2019 Innovations in Oral Therapies for Inflammatory Bowel Disease Brian Feagan, Christopher Ma, Vipul Jairath Read Now
Publication May 14, 2019 What is the role of C-reactive protein and fecal calprotectin in evaluating Crohn’s disease activity? Brian Feagan, Christopher Ma, Vipul Jairath Read Now
Publication May 14, 2019 Advances in Therapeutic Drug Monitoring for Small-Molecule and Biologic Therapies in Inflammatory Bowel Disease Christopher Ma, Niels Vande Casteele, Vipul Jairath Read Now
Publication May 14, 2019 Update on C-reactive protein and fecal calprotectin: are they accurate measures of disease activity in Crohn’s disease? Brian Feagan, Christopher Ma, Vipul Jairath Read Now
Publication May 14, 2019 Systematic review with meta-analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel disease Brian Feagan, Christopher Ma, Niels Vande Casteele, Vipul Jairath Read Now
Publication May 14, 2019 IL12/23 or selective IL23 inhibition for the management of moderate-to-severe Crohn’s disease? Brian Feagan, Christopher Ma, Vipul Jairath Read Now
